Pr Seeman - CurveBeam Medical Endocrinology
CVB Stock | 0.13 0.01 7.14% |
Executive
Pr Seeman is Medical Endocrinology of CurveBeam AI Limited
Address | 2800 Bronze Drive, Hatfield, PA, United States, 19440 |
Phone | 267-483-8081 |
Web | https://curvebeamai.com |
Similar Executives
Showing other executives | EXECUTIVE Age | ||
Rebecca Ackland | Southern Cross Media | N/A | |
Nikki Clarkson | Southern Cross Media | N/A | |
Kelly Stambanis | Southern Cross Media | N/A | |
Tim Young | Southern Cross Media | N/A | |
Toby Potter | Southern Cross Media | N/A | |
Anthony Hudson | Southern Cross Media | N/A | |
Rochelle Burbury | Southern Cross Media | N/A | |
Doug Winzar | Falcon Metals | N/A | |
Stephen Haddad | Southern Cross Media | N/A | |
Dave Cameron | Southern Cross Media | N/A | |
AGIA BCom | Falcon Metals | N/A | |
ACA BEc | Southern Cross Media | N/A | |
Brian Gallagher | Southern Cross Media | N/A | |
ACIS BCom | Southern Cross Media | N/A | |
Seb Rennie | Southern Cross Media | N/A |
Management Performance
Return On Equity | -2.87 | ||||
Return On Asset | -0.21 |
CurveBeam AI Limited Leadership Team
Elected by the shareholders, the CurveBeam's board of directors comprises two types of representatives: CurveBeam inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CurveBeam. The board's role is to monitor CurveBeam's management team and ensure that shareholders' interests are well served. CurveBeam's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CurveBeam's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ura Auckland, CFO Secretary | ||
Turner Dean, Chief Officer | ||
Pr Seeman, Medical Endocrinology | ||
Aloys Mbala, CoFounder | ||
Vinti Singh, Vice Marketing | ||
Arun Singh, CTO COO | ||
Yu BS, Chief Officer | ||
Ali Ghasemzadeh, CoFounder |
CurveBeam Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CurveBeam a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -2.87 | ||||
Return On Asset | -0.21 | ||||
Operating Margin | (3.01) % | ||||
Current Valuation | 60.16 M | ||||
Shares Outstanding | 389.8 M | ||||
Shares Owned By Insiders | 40.53 % | ||||
Shares Owned By Institutions | 29.59 % | ||||
Price To Book | 1.30 X | ||||
Price To Sales | 7.76 X | ||||
Revenue | 6.53 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for CurveBeam Stock Analysis
When running CurveBeam's price analysis, check to measure CurveBeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CurveBeam is operating at the current time. Most of CurveBeam's value examination focuses on studying past and present price action to predict the probability of CurveBeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CurveBeam's price. Additionally, you may evaluate how the addition of CurveBeam to your portfolios can decrease your overall portfolio volatility.